Related Experiment Videos
Uveitis associated with childhood rheumatic diseases
1Department of Pediatrics, University of Saskatchewan, Royal University Hospital, Canada. rosenberg@sask.usask.ca
Current Opinion in Rheumatology
|August 23, 2002
Summary
Childhood rheumatic diseases can affect the eyes, causing uveitis. New immunomodulatory therapies, including biologics, offer improved treatment options for this debilitating condition.
Area of Science:
- Ophthalmology
- Rheumatology
- Pediatrics
Background:
- Childhood rheumatic diseases often involve multiple body systems.
- Ocular inflammation, specifically uveitis, is a common and potentially severe extra-articular manifestation.
- Anterior uveitis linked to oligoarticular juvenile idiopathic arthritis is a distinct presentation.
Purpose of the Study:
- To review recent literature on childhood uveitis associated with rheumatic diseases.
- To clarify the range of conditions causing uveitis in children.
- To discuss new therapeutic strategies for childhood uveitis.
Main Methods:
- Literature review of recent contributions.
- Analysis of immunopathogenic mechanisms in childhood uveitis.
- Evaluation of novel immunomodulatory and biologic therapies.
Main Results:
- Uveitis is a significant ocular complication in various childhood rheumatic diseases.
- Specific rheumatic conditions are associated with distinct patterns of uveitis (anterior, posterior, intermediate).
- Emerging immunomodulatory treatments show promise for managing childhood uveitis.
Conclusions:
- Understanding the multisystem nature of rheumatic diseases is crucial for managing ocular involvement.
- New biologic agents represent a significant advancement in treating childhood uveitis.
- Further research into immunopathogenesis will guide more targeted therapies.